Connor, Clark & Lunn Investment Management »

Prelude Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $134k 46k 2.90
2024-09-30 $36k 17k 2.07
2024-06-30 $47k 12k 3.81
2024-03-31 $95k 20k 4.74

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Toronto Dominion Bk Ont Com New (TD)
Cibc Cad (CM)
NVIDIA Corporation (NVDA)
Bk Nova Cad (BNS)
Apple (AAPL)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Tc Energy Corp (TRP)
Celestica (CLS)
Enbridge (ENB)
Amazon (AMZN)
Barrick Mng Corp Com Shs (B)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Vanguard Group
Millennium Management
Kynam Capital Management
Acadian Asset Management
Marshall Wace
Geode Capital Management
Renaissance Technologies
BlackRock
Two Sigma Advisers
Susquehanna International
TD Asset Management
Two Sigma Investments
State Street Corporation

View all funds holding Prelude Therapeutics